The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1494646
WO Application Number:
EP2003003305
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP03744867.7
WO Publication Number:
WO2003080018
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Ireland (IE)
Publications:
Dates
Filing date:
27/03/2003
Grant date:
11/07/2012
EP Publication Date:
12/01/2005
WO Publication Date:
02/10/2003
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
28/12/2017
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/07/2012
EP B1 Publication Date:
11/07/2012
EP B2 Publication Date:
04/10/2017
EP B3 Publication Date:
Description Translation B1 Received Date:
03/09/2012
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/03/2023
Lapsed By Expiration Date:
27/03/2023
Patent Validated Date:
12/01/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
07/12/2021
Name:
Allergan Therapeutics LLC
Address:
5 Giralda Farms, 07940, Madison, NJ, United States of America (US)
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995
4
Bulletin Heading:
CO
Journal edition number:
44/17
Publication date:
01/11/2017
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
EP4
Journal edition number:
40/17
Publication date:
04/10/2017
Description:
European patents granted in amended form for the Netherlands
6
Bulletin Heading:
MED
Journal edition number:
40/17
Publication date:
04/10/2017
Description:
Other communications
7
Bulletin Heading:
VB1
Journal edition number:
2013/23
Publication date:
05/06/2013
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
8
Bulletin Heading:
EP3
Journal edition number:
2012/38
Publication date:
19/09/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
9
Bulletin Heading:
EP2
Journal edition number:
2012/29
Publication date:
18/07/2012
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
201740
Publication date:
04/10/2017
Description:
Patent maintained (B2 publication)
2
Issue number:
201446
Publication date:
12/11/2014
Description:
Title of invention Modified
3
Issue number:
201322
Publication date:
29/05/2013
Description:
Opposition procedure started
4
Issue number:
201228
Publication date:
11/07/2012
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102599C
Date Registered:
07/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.C. Volmer c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Allergan Therapeutics LLC
Address:
5 Giralda Farms, 07940, Madison, NJ, United States of America (US)